Hereditary oral squamous cell carcinoma associated with CDKN2A germline mutation: a case report

Journal of Otolaryngology - Head & Neck Surgery

Ah-Reum Jeong¹  Kimberly Forbes¹  Ezra E. W. Cohen²  Ryan K. Orosco³ 

[1] Division of Hematology and Oncology, Department of Medicine, University of California San Diego, 3855 Health Sciences Drive, 92093-0960, La Jolla, CA, USA;Division of Hematology and Oncology, Department of Medicine, University of California San Diego, 3855 Health Sciences Drive, 92093-0960, La Jolla, CA, USA;Moores Cancer Center, University of California San Diego, 92093, La Jolla, CA, USA;Division of Otolaryngology, Department of Surgery, University of California San Diego, 92093, La Jolla, CA, USA;Moores Cancer Center, University of California San Diego, 92093, La Jolla, CA, USA;

关键词: CDKN2A germline mutation;    Familial atypical multiple moles melanoma;    Head and neck squamous cell cancer;    Oral squamous cell cancer;    Case report;   

DOI  :  10.1186/s40463-022-00556-y

来源: Springer

【 摘 要 】

BackgroundGermline CDKN2A mutations are a well-known cause of familial atypical multiple mole melanoma (OMIM #155601) and melanoma-pancreatic cancer syndrome (OMIM #606719). Increased risk of head and neck squamous cell carcinoma (HNSCC), particularly oral squamous cell carcinoma (OSCC) in those with germline CDKN2A mutations, has been described. However, screening for HNSCC is not a routine practice in patients with CDKN2A germline mutations and these mutations are not a conventional test for HNSCC patients without obvious risk factors.Case presentationWe describe a female with no smoking history who developed oral squamous cell carcinoma at age 39 and had a complex clinical course of recurrent multifocal squamous cell carcinoma (SCC) and carcinoma in situ of the oral cavity and oropharynx. Detailed family history demonstrated that her mother was diagnosed with OSCC and melanoma in her 40 s, and her maternal grandfather was diagnosed with metastatic melanoma in his 40 s. Genetic testing of the patient and her mother revealed CDKN2A c.301G>T mutation. She was referred to genetic counseling as well as to dermatology, gastroenterology, and neurology for cancer surveillance. She was treated with resections and has no evidence of disease 3 years after diagnosis.ConclusionsWe report a family with a CDKN2A c.301 G>T mutation who also have significant history of OSCC, adding to the growing body of literature suggesting increased risk of HNSCC, particularly OSCC, in CDKN2A germline mutation carriers. It is important to consider CDKN2A mutation testing in familial HNSCC and young patients without obvious risk factors. Moreover, surveillance for HNSCC should be routine practice in those with a CDKN2A germline mutation.Graphical abstract

【 授权许可】

CC BY